Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Alosetron emerging as safe and effective treatment for IBS in female patients

May 21, 1998

Intron A/Rebetol combination shows promise in treatment-naive patients

May 21, 1998

T-593 exhibits antiulcer activity via a dual mechanism of action

May 21, 1998

REFAC Biochemics and NYHQ will evaluate Pyloricide for the treatment of peptic ulcers

May 20, 1998

Novel prokinetic agent, R-93877, accelerates upper gut and colonic transit in humans

May 20, 1998

Spotlight on treatment and prevention of C. difficile infection

May 19, 1998

SciClone and Schering-Plough begin phase III trial of Zadaxin in Japan

May 18, 1998

Pharmacological profile of lafutidine and related compounds

May 15, 1998

Selective somatostatin receptor antagonist reported for pancreatic disorders

May 12, 1998

Compounds for GI tract motility disorders claimed by Yamanouchi

May 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...